BamSEC and AlphaSense Join Forces
Learn More

Equillium Inc. – Material Contracts

NASDAQ: EQ    
Share price (6/1/26): $3.08    
Market cap (6/1/26): $195 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.11
from 10-K 3 pages Equillium, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.1
from 8-K 38 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 48 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 46 pages Open Market Sale Agreementsm
12/34/56
EX-10.1
from 8-K 24 pages Equillium, Inc. 2018 Equity Incentive Plan Adopted by the Board of Directors: October 1, 2018 Approved by the Stockholders: October 1, 2018 Ipo Date: October 11, 2018 Amended by the Board of Directors: March 26, 2025 Approved by the Stockholders: May 21, 2025
12/34/56
EX-10.24
from 10-K 56 pages Certain Information Contained in This Exhibit, Marked by [***], Has Been Excluded From This Exhibit Because the Registrant Has Determined That It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential
12/34/56
EX-10.1
from 10-Q 46 pages Equillium, Inc. 2024 Inducement Plan Adopted by the Board of Directors: March 6, 2024
12/34/56
EX-10.2
from 10-Q 18 pages Clinical Supply Agreement
12/34/56
EX-10.1
from 10-Q 38 pages Collaboration and License Agreement
12/34/56
EX-10
from 10-K 90 pages Asset Purchase Agreement Between Ono Pharmaceutical Co., Ltd., and Equillium, Inc. Dated as of December 5, 2022
12/34/56
EX-10
from 10-K 3 pages Fifth Amendment to Collaboration and License Agreement
12/34/56
EX-10.29
from 10-K 11 pages Confidential Separation Agreement and General Release of All Claims
12/34/56
EX-10.25
from 10-K 3 pages Equillium, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.3
from 10-Q 8 pages Fourth Amendment to Collaboration and License Agreement This Fourth Amendment to Collaboration and License Agreement
12/34/56
EX-10.29
from 10-K 2 pages Equillium, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.28
from 10-K 5 pages Original Offer Letter Date: August 31, 2018 First Amendment to Offer Letter Effective: January 1, 2020 Amended and Restated Effective: January 26, 2021 Joel Rothman Po Box 326 Moss Beach, Ca 94038 Re:amended and Restated Employment Terms
12/34/56
EX-10.1
from 8-K 11 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 6 pages December 15, 2020 Dolca Thomas, M.D. 2207 Sweeney Lane Alameda, Ca 94501 Re: Offer of Employment Dear Dolca: Equillium, Inc. (The “Company”) Is Pleased to Offer You the Position of Executive Vice President of Research & Development & Chief Medical Officer on the Following Terms
12/34/56
EX-10.1
from 10-Q 2 pages Equillium, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.1
from 8-K 40 pages Purchase Agreement
12/34/56